RECURRENT RENAL CELL CARCINOMA
Clinical trials for RECURRENT RENAL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT RENAL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for RECURRENT RENAL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Two-Drug combo aims to starve and attack advanced cancers
Disease control OngoingThis early-phase trial tests the safety and best dose of combining two drugs—ziv-aflibercept and pembrolizumab—in people with advanced solid tumors that have spread. Ziv-aflibercept cuts off the tumor's blood supply, while pembrolizumab helps the immune system fight cancer. The s…
Matched conditions: RECURRENT RENAL CELL CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 07:49 UTC
-
New hope for kids with rare cancers: drug blocks tumor growth
Disease control OngoingThis study tests a daily pill called cabozantinib in children and young adults (up to age 30) with rare cancers like sarcomas, Wilms tumor, and others that have come back or not responded to treatment. The drug works by blocking signals that help tumors grow and form blood vessel…
Matched conditions: RECURRENT RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 07:27 UTC
-
New combo therapy aims to boost immune attack on kidney cancer
Disease control OngoingThis study tests whether adding an experimental drug (anti-OX40 antibody) to a standard targeted therapy (axitinib) can help control advanced kidney cancer that has spread. About 62 adults whose cancer worsened after prior immunotherapy will receive either the combination or axit…
Matched conditions: RECURRENT RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: University of Southern California • Aim: Disease control
Last updated May 22, 2026 14:05 UTC
-
New combo therapy shows promise for HIV patients with advanced cancer
Disease control OngoingThis early-phase trial is testing the safety of combining two cancer drugs—nivolumab and cabozantinib—in people with HIV who have advanced solid tumors. The study includes 8 participants with various cancers that have spread. The goal is to see if the combination can shrink or st…
Matched conditions: RECURRENT RENAL CELL CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 11, 2026 20:38 UTC
-
Simple test could spot kidney cancer early
Knowledge-focused OngoingThis study is testing a new lab test that looks at blood and urine samples to find and track kidney cancer. Researchers want to see if the test can detect cancer early, monitor how well treatment is working, and spot if the cancer comes back. The study includes healthy people, pa…
Matched conditions: RECURRENT RENAL CELL CARCINOMA
Sponsor: University of Southern California • Aim: Knowledge-focused
Last updated May 26, 2026 07:24 UTC